goBalto announced that ICON has chosen goBalto s flagship product Activate to bolster ICON s clinical study startup process on a worldwide basis. ICON is using Activate for all global studies, which span more than 50 countries. ICON has already integrated Activate with its CTMS and data warehouOriginal Article
You may also like
Ariane de Ganck
Jasper Therapeutics merges with Kira Pharmaceuticals
Lilly to acquire AtaiBeckley in deal worth $2.8bn
Camena Bioscience appoints Gregory McGuinness as CEO
New €25 Million BioReliance Testing Facility Opens...
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
